Ipsen obtains an exclusive license to develop, manufacture and commercialize a pre-clinical stage METTL3-inhibitor programme
CuraTeQ Biologics is on track for filing a second oncology biosimilar
Sandoz is committed to building on its leading generic and biosimilar oncology portfolio to further expand patient access while contributing to the sustainability of healthcare systems
The transactions resulted in a net cash inflow of Rs 183 crores for HCG in addition to the take-over of the labs and clinical research business
The foundation has been working closely with the Kidwai Memorial Institute of Oncology on several projects since 2001
The partnership is a significant step in delivering advanced cancer therapies to patients.
Kedar Upadhye has also been appointed as Chief Financial Officer of Biocon Limited
Since launching, the hospital has performed over 40 intestinal transplants, including 21 in 2025 alone
TERN-701, a next-generation therapy targeting chronic myeloid leukemia (CML), a form of blood cancer that still presents treatment challenges despite decades of advances
Doctors at the hospital highlighted that robotic-assisted surgery enhances precision through superior 3D visualisation and improved instrument flexibility
Subscribe To Our Newsletter & Stay Updated
